Mivavotinib (monohydrochloride), CAS [[1952251-28-3]]

Produktübersicht

• Artikelname: Mivavotinib (monohydrochloride), CAS [[1952251-28-3]]
• Artikelnummer: MCE-HY-100867A
• Hersteller Artikelnummer: HY-100867A
• Alternativnummer: MCE-HY-100867A-5MG,MCE-HY-100867A-100MG,MCE-HY-100867A-25MG,MCE-HY-100867A-10MG,MCE-HY-100867A-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: TAK-659 (monohydrochloride), CB-659 (monohydrochloride)

Produktbeschreibung

TAK-659 hydrochloride is a highly potent, selective, reversible and orally available dual inhibitor of spleen tyrosine kinase (SYK) and fms related tyrosine kinase 3 (FLT3), with an IC50 of 3.2 nM and 4.6 nM for SYK and FLT3, respectively. TAK-659 hydrochloride induces cell death in tumor cells but not in nontumor cells, and with potential for the treatment of chronic lymphocytic leukemia (CLL)[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: 380.85
• Reinheit: 99.91
• CAS Nummer: [1952251-28-3]
• Formel: C17H22ClFN6O
• Target-Kategorie: FLT3,Syk

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound